3
July 22 (Reuters) – GSK plc: * GSK PLC – JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS * GSK – FDA APPROVAL GRANTED AHEAD OF ORIGINAL TARGET DATE OF 18 SEPTEMBER 2026 Source text: Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
